Interferon-gamma therapy in two patients with progressive chronic pulmonary aspergillosis.
about
Optimizing Outcomes in Immunocompromised Hosts: Understanding the Role of Immunotherapy in Invasive Fungal DiseasesClinical implications of interferon-γ genetic and epigenetic variantsEarly NK cell-derived IFN-{gamma} is essential to host defense in neutropenic invasive aspergillosis.Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection.Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series.Adaptive immunity to fungi.Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosisCurrent options in antifungal pharmacotherapy.Regulation of immunity in bronchiectasis.A novel insight into the immunologic basis of chronic granulomatous invasive fungal rhinosinusitis.Scedosporium prolificans: an emerging pathogen in France?Managing fungal and viral infections in pediatric leukemia.Immune response to Aspergillus fumigatus in compromised hosts: from bedside to bench.Cytokines and the regulation of fungus-specific CD4 T cell differentiation.Immune modulators as adjuncts for the prevention and treatment of invasive fungal infections.Chronic pulmonary aspergillosis.Cytokine networking of innate immunity cells: a potential target of therapy.Republished: The clinical spectrum of pulmonary aspergillosis.Immunomodulation by IFN-γ in patients with resistant infections and accompanying bronchiolitis obliterans following allo-SCT.Chronic Pulmonary Aspergillosis-Where Are We? and Where Are We Going?Aspergillus fumigatus Cell Wall α-(1,3)-Glucan Stimulates Regulatory T-Cell Polarization by Inducing PD-L1 Expression on Human Dendritic Cells.Innate and Adaptive Immune Defects in Chronic Pulmonary Aspergillosis.Human NK Cells Develop an Exhaustion Phenotype During Polar Degranulation at the Hyphal Synapse
P2860
Q26774692-E7FFC4B7-A265-42E7-9744-1969036976C0Q28383437-858C2E62-69EA-4C00-92FA-08AF31FAE061Q30433397-D2E80090-1B3F-4549-A51E-44ACA7BCEC59Q30585324-18FCFAD5-AED1-4BDF-8960-510678506384Q35131761-E844255A-7436-472F-83AD-F298D6A925ACQ35164257-7C4AFECE-B185-4BBE-9812-73FCB556894DQ35679674-F0D5BAFA-9D69-449D-9619-901C70180835Q37151326-14870A95-95D6-4088-877A-FC3E1863A4F1Q37209962-3E521D91-DF68-464D-BDFE-433ABAAEED6AQ37230359-78D5F709-DC35-4845-807D-93275A4BA59AQ37351705-F7584984-ED5F-42F7-8346-E395DCC32216Q37810281-0C81CEDE-8359-4669-A99B-0C72FB4E950AQ37821488-9CA713EC-A501-4ABA-AF14-00C8A3154C0FQ37963574-38AAA7F0-8BDB-498D-8BD6-2AEE8D06D807Q38067451-E910C46D-7F73-477D-86E3-C0D9CA212563Q38168300-E3501B72-F4FA-477D-A51A-D4FF2C9F0C98Q38180799-63F087BB-CEB2-4D61-AEDF-CACCCB069B37Q38549796-104A0FA5-5D6F-4A3E-B6FE-9BEC910667B7Q43592901-25FC5778-F2DA-4177-926E-3347FDBEBBCCQ47645128-528018CF-752D-4B26-A060-86E47A44B1EAQ47714769-7C2DAA82-A835-415E-91AF-FCFACAE3D5FAQ48163237-5DD21C59-6469-4C61-BB2A-10D84B6C8C3FQ58580451-AC23226A-AFCB-4B07-929C-5CC64783655B
P2860
Interferon-gamma therapy in two patients with progressive chronic pulmonary aspergillosis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Interferon-gamma therapy in tw ...... ronic pulmonary aspergillosis.
@en
Interferon-gamma therapy in tw ...... ronic pulmonary aspergillosis.
@nl
type
label
Interferon-gamma therapy in tw ...... ronic pulmonary aspergillosis.
@en
Interferon-gamma therapy in tw ...... ronic pulmonary aspergillosis.
@nl
prefLabel
Interferon-gamma therapy in tw ...... ronic pulmonary aspergillosis.
@en
Interferon-gamma therapy in tw ...... ronic pulmonary aspergillosis.
@nl
P2093
P1476
Interferon-gamma therapy in tw ...... ronic pulmonary aspergillosis.
@en
P2093
A Goodsall
A Mulgirigama
A Newman-Taylor
D C Henderson
P Kelleher
P304
P356
10.1183/09031936.06.00021705
P577
2006-06-01T00:00:00Z